Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director · Chairman and CEO | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,945 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 52,945 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
ICU MEDICAL INC/DE
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,106 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Exercise / conversion · Acquired 17,100 · Balance 134,106 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Direct | 124,654 |
Reported balance
After 2026-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-15 · Tax withholding · Disposed 9,452 · Balance 124,654 F1: These Securities are Performance-based Restricted Stock Units (PRSU). |
| Common StockSEC Table I · non-derivative | Direct | 129,526 |
Reported balance
After 2026-03-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-03-15 · Exercise / conversion · Acquired 4,872 · Balance 129,526 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 126,833 |
Reported balance
After 2026-03-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-03-15 · Tax withholding · Disposed 2,693 · Balance 126,833 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-15 · Exercise / conversion · Disposed 4,872 · Balance 0 F3: These securities are Restricted Stock Units. F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-15 · Exercise / conversion · Disposed 17,100 · Balance 0 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F5: There is neither a purchase price nor an exercise price for the PRSUs. F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 152,339 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 152,339 |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
F3: These securities are Restricted Stock Units.
F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F5: There is neither a purchase price nor an exercise price for the PRSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 28, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 164 | $58.79 | $9,641.56 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000008 · edgardoc.xml · derivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,366 Underlying: Common Stock · 12,000 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000008 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,366 Underlying: Common Stock · 12,000 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 12,000 | $240.00 | $2,880,045.60 |
DisclosureSEC source: 0001410442-21-000008 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,000 | $58.79 | $705,480.00 |
DisclosureSEC source: 0001410442-21-000008 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 12,000 | $240.00 | $2,880,000.00 |
DisclosureSEC source: 0001410442-21-000008 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,000 | $58.79 | $705,480.00 |
DisclosureSEC source: 0001410442-21-000008 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:46 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 4,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-21-000080 · wf-form4_162214831066826.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,220 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the date of the Issuer's 2022 Annual Meeting of Stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. RSUs are payable in shares of common stock on a one-to-one basis. F2 · balance_after: Includes 9,200 RSUs that were previously reported in Table II. Read SEC document |
| May 24, 2021 Filed May 24, 2021 15:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000007 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| May 20, 2021 Filed May 24, 2021 15:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000007 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,819 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 7,574 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,574 Underlying: Common Stock · 7,574 shares Expires 2024-03-08 F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,681 shares Expires 2021-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,772 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,545 Underlying: Common Stock · 1,772 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 932 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,844 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,004 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,320 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 22:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 8,044 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000005 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,044 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F4 · derivative.exercise_date: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs had a February 15 vest date subject to approval by the Compensation Committee, which occurred on February 18. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 22:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 4,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,050 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 22:31 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 8,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 38,591 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,366 Underlying: Common Stock · 38,591 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the vesting commencement date of February 13, 2014 and in equal monthly installments thereafter for three additional years. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 38,591 | $220.00 | $8,490,020.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 38,591 | $58.79 | $2,268,764.89 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,070 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,957 Underlying: Common Stock · 6,070 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the vesting commencement date of February 13, 2014 and in equal monthly installments thereafter for three additional years. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 6,070 | $220.00 | $1,335,400.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 6,070 | $58.79 | $356,855.30 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,973 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,027 Underlying: Common Stock · 10,973 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the vesting commencement date of February 13, 2014 and in equal monthly installments thereafter for three additional years. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,366 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · derivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 13,366 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 24,339 | $220.00 | $5,354,580.00 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 10,973 | $58.79 | $645,102.67 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 13,366 | $58.79 | $785,787.14 |
DisclosureSEC source: 0001410442-21-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,366 Underlying: Common Stock · 11,500 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F10 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 200 | $216.42 | $43,283.96 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.29 to $216.72, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,533 | $215.58 | $330,477.24 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,441 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.11 to $214.77, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 300 | $214.33 | $64,299.99 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,974 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.11 to $214.77, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 708 | $213.45 | $151,124.65 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,274 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.91 to $213.78, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,759 | $212.10 | $1,009,376.76 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,982 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.89 to $212.87, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,500 | $211.54 | $528,847.00 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,741 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.86 to $211.72, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 700 | $210.30 | $147,211.47 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.84 to $210.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 800 | $209.24 | $167,390.56 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,941 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.65 to $209.61, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:15 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 11,500 | $58.79 | $676,085.00 |
DisclosureSEC source: 0001410442-21-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:06 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,200 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-20-000011 · edgardoc.xml · derivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,866 Underlying: Common Stock · 9,200 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:06 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 9,200 | $195.00 | $1,794,000.00 |
DisclosureSEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:06 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 9,200 | $58.79 | $540,868.00 |
DisclosureSEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:06 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,300 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-20-000011 · edgardoc.xml · derivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,066 Underlying: Common Stock · 2,300 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F4 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:06 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,300 | $195.00 | $448,500.00 |
DisclosureSEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,241 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:06 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,300 | $58.79 | $135,217.00 |
DisclosureSEC source: 0001410442-20-000011 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.